Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 12:23 AM ET


Company Overview of Glycos Biotechnologies, Inc.

Executive Profile

Richard C. Cilento Jr.

Chairman and Chief Executive Officer, Glycos Biotechnologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships


Mr. Richard C. Cilento, Jr., also known as Rich, serves as Chief Executive Officer at GlycosBio Asia Sdn Bhd. Mr. Cilento serves as Executive Chairman and Chief Executive Officer at Glycos Biotechnologies, Inc. He serves as a Venture Advisor at Mercury Fund. He serves as an Advisor to a number of small businesses. Mr. Cilento was the Founder, President, and Chief Executive Officer at FuelQuest, Inc. Prior to the firm, he was the Co-Founder and Principal at The Bollard ...

Corporate Headquarters

711 Leverkuhn Street
Houston, Texas 77007

United States

Phone: 713-869-9377
Fax: 713-869-2200

Board Members Memberships

Chairman and Chief Executive Officer
Chief Executive Officer and Director


University of Illinois-Urbana-Champaign
University of Houston System

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Glycos Biotechnologies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at